FDA Inspection 654888 — Pharbest Pharmaceuticals, Inc.

Pharbest Pharmaceuticals, Inc. — FEI 3005382247

The FDA completed an inspection of Pharbest Pharmaceuticals, Inc. on Mar 30, 2010 in Farmingdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 30, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
192721 CFR 211.166(b)Accelerated stability studies
194221 CFR 211.180(e)Records reviewed annually
200921 CFR 211.188Prepared for each batch, include complete information
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
363221 CFR 211.170(b)Annual visual exams of drug products
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.